17 Jan 2020 10:51
Open Orphan Takeover Of hVIVO Now Wholly Unconditional
Open Orphan Takeover Of hVIVO Now Wholly Unconditional
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
ORPH.L Share News (ORPH)
ORPH Share
Price
ORPH Share
News
ORPH Share
Chat
ORPH Share
Trades
ORPH
Live RNS
ORPH Share
Charts
ORPH Broker
Ratings
ORPH Directors
Deals
ORPH Financial
Diary
ORPH
Fundamentals
ORPH Short
Positions
ORPH
Media
ORPH.L Information
- There is currently no data for ORPH
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.16 Jan 2020 18:15
Open Orphan Readmitted To AIM Following Reverse Takeover Of hVIVO
Open Orphan Readmitted To AIM Following Reverse Takeover Of hVIVO
Read more14 Jan 2020 16:10
Open Orphan To Mount Compulsory Buyout To Get hVIVO Deal Over Line
Open Orphan To Mount Compulsory Buyout To Get hVIVO Deal Over Line
Read more6 Jan 2020 17:29
UPDATE: Open Orphan To Relist On AIM Following hVIVO All-Share Merger
UPDATE: Open Orphan To Relist On AIM Following hVIVO All-Share Merger
Read more6 Jan 2020 11:49
Open Orphan To Relist On AIM Following hVIVO All-Share Merger
Open Orphan To Relist On AIM Following hVIVO All-Share Merger
Read more6 Jan 2020 10:55
Open Orphan inks three-year contract with mystery European firm
(Sharecast News) - Drug consulting services platform Open Orphan has won a new three-year contract with an unnamed German pharmaceutical company.
Read more31 Dec 2019 09:46
Open Orphan Meets Acceptance Condition For Merger With hVIVO
Open Orphan Meets Acceptance Condition For Merger With hVIVO
Read more31 Dec 2019 06:31
UK Shareholder Meetings Calendar - Next 7 Days
UK Shareholder Meetings Calendar - Next 7 Days
Read more18 Dec 2019 12:54
Open Orphan signs deal with US biopharmaceutical firm SFA
(Sharecast News) - Europe-focussed rare and orphan drug consulting service provider Open Orphan announced the signing of a contract with SFA Therapeutics, a biopharmaceutical company based in Pennsylvania, on Wednesday.
Read more18 Dec 2019 12:29
Open Orphan Unit To Assist SFA Therapeutics In Filing Drug Application
Open Orphan Unit To Assist SFA Therapeutics In Filing Drug Application
Read more9 Dec 2019 14:36
Open Orphan agrees acquisition of hVIVO at 34% premium
(Sharecast News) - Open Orphan, the rare and orphan drug services company, has agreed the takeover of hVIVO by means of an all-share reverse take-over at a 33.8% premium.
Read more9 Dec 2019 11:23
AIM-Listed Firms Open Orphan And hVIVO Set For Tie-Up
AIM-Listed Firms Open Orphan And hVIVO Set For Tie-Up
Read more25 Nov 2019 14:57
Open Orphan Signs Five Companies For Genomic Health DataBANK Platform
Open Orphan Signs Five Companies For Genomic Health DataBANK Platform
Read more18 Nov 2019 10:35
Open Orphan Teams With Carna For Human Clinical Pharmacology Trial
Open Orphan Teams With Carna For Human Clinical Pharmacology Trial
Read more18 Nov 2019 09:58
Open Orphan signs pharmacology trial contract with Carna
(Sharecast News) - Rare and orphan drug consulting services provider Open Orphan announced the signing of a contract with Carna Bioscience for a first-in-human clinical pharmacology trial, it announced on Monday.
Read more